Nutrisystem (NTRI) Tops Q3 EPS by 3c; Raises Outlook

Nutrisystem (NASDAQ: NTRI) reported Q3 EPS of $0.49, $0.03 better than the analyst estimate of $0.46. Revenue for the quarter came in at $158.1 million versus the consensus estimate of $155.21 million.

GUIDANCE:

Nutrisystem sees Q4 2017 EPS of $0.37-$0.42, versus the consensus of $0.40. Nutrisystem sees Q4 2017 revenue of $126-131 million, versus the consensus of $127.21 million.

Nutrisystem sees FY2017 EPS of $1.91-$1.96, versus the previous range of $1.84 to $1.94 and the consensus of $1.91. Nutrisystem sees FY2017 revenue of $692-697 million, versus the consensus of $690 million.

For earnings history and earnings-related data on Nutrisystem (NTRI) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• InspireMD (NSPR) Tops Q2 EPS by 1c